In line with context-dependent functions of ARID1A, a recent study in HCC provides additional insights into the link between epigenetic regulatory function of ARID1A to cancer metabolism, which may offer a new possibility of targeting the metabolic vulnerability in certain HCC patients. Here, ARID1A is linked to hepatocellular carcinoma.